Avanthi Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVANTHI INC, and what generic and branded alternatives to AVANTHI INC drugs are available?
AVANTHI INC has ten approved drugs.
Summary for Avanthi Inc
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
Drugs and US Patents for Avanthi Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanthi Inc | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET;ORAL | 203601-001 | Jan 30, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Avanthi Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 091393-005 | Aug 31, 2009 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Avanthi Inc | DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 078648-001 | Feb 27, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Avanthi Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 091393-004 | Aug 31, 2009 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
